Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain.
While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects. They are focused on treating pain locally – at its source.
Vapogenix was founded by Dr. Allen Burton, Dr. Phillip Phan and Ms. Danguole Altman. They began operations in November 2007 after licensing intellectual property rights to their core technology. Dr. Burton and Dr. Phan were searching for non-narcotic pain medications to alleviate the chronic neuropathic pain experienced by many of their patients - cancer survivors.